Convalescent Plasma Therapy: An aspiring option for COVID-19 treatment?
Open Access
- 31 December 2020
- journal article
- Published by Haematology Society of Bangladesh in Haematology Journal of Bangladesh
- Vol. 4 (02), 52-56
- https://doi.org/10.37545/haematoljbd202054
Abstract
COVID-19 is a cause of life threating severe acute respiratory syndrome (SARS) caused by a novel corona virus named as SARS-Cov-2. Since it has 1st been identified in the city of Wuhan in China in December, 2019, it has spread rapidly all over the world. As it is a newly emerged viral infection and any vaccine or specific therapy yet to be proven as clearly effective, multiple therapeutic option with supportive intent as well as search for specific therapy to combat the virus are under vigorous trial around the world. Convalescent plasma therapy is one such investigational therapeutic option for COVID-19 with hope that neutralizing antibodies present in plasma of persons recovered from COVID-19 would be able to neutralize the virus in infected person.Keywords
This publication has 13 references indexed in Scilit:
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaJAMA, 2020
- Convalescent plasma as a potential therapy for COVID-19The Lancet Infectious Diseases, 2020
- Emerging infectious diseases: A proactive approachProceedings of the National Academy of Sciences of the United States of America, 2017
- Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi ArabiaEmerging Infectious Diseases, 2016
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Treatment with Convalescent Plasma for Influenza A (H5N1) InfectionThe New England Journal of Medicine, 2007
- Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?Annals of Internal Medicine, 2006
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent PatientsThe Journal of Infectious Diseases, 1999
- The use of Lassa fever convalescent plasma in NigeriaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1984